Newsletter Archive
Newsletter nr. 1 - March 2010
- New possibilities in targeting the human immune system
- Experienced formulation specialist joins Bioneer:FARMA
- Novel promising protein drug targets for inflammation
- Danish Stem Cell Initiative kick off
- FDA sponsors Bioneer:FARMA development on Quality-by-Design